Company Name: Prana Biotechnology Limited
Prana Biotechnology Limited is engaged in the development of therapies for neurodegenerative diseases. The company’s lead product candidate is a treatment for Alzheimer’s and Huntington’s diseases.
Ticker Symbol: PRAN (NASDAQ)
Ticker Symbol: PBT (ASX)
Company Website: http://pranabio.com
Headquarters: Parkville, Victoria, Australia